When Science Meets Humanity: A New Era in Treating Eating Disorders

Eating disorders are the deadliest of all mental health conditions — but with the right science and the right people, we believe healing is within reach.

At NeoLumina BioScience, we don’t just see data points — we see lives. Behind every eating disorder diagnosis is a daughter, a friend, a story interrupted too soon. The tragic reality is that eating disorders take more lives than any other mental health disorder, and most often begin in the very young, particularly among women.

But there is hope. And it’s emerging from the frontiers of psychedelic science.

New research is revealing how psychedelics, when administered safely and clinically, can help the brain reconnect, rewire, and ultimately heal. It’s a shift not just in treatment, but in the very framework of how we understand mental health.

Leading this mission are Dr. Mark Gold and Dr. Wendy Oliver-Pyatt, two internationally respected psychiatric experts who have dedicated their lives to transforming mental health care. They are backed by NeoLumina’s world-class team of scientists, with decades of experience in clinical trials, pharmaceutical development, and compassionate innovation.

We are focused. We are experienced. And we are determined.

Because when science meets humanity, true healing begins.

Watch the message from our CEO below: